
|Articles|June 16, 2023
Regulatory Spotlight - Compendia Updates: USP <621> and USP <1220>
Author(s)Eurofins BioPharma Product Testing
Compendia publications are periodically updated in order to align with industry trends and harmonize with global regulatory practices. Staying abreast of these changes well before they are implemented, and being ready to adapt as necessary, is in the best interest of any bio/pharmaceutical testing laboratory. Eurofins BioPharma Product Testing has proactively adjusted its procedures, collaborating with stakeholders and providing feedback to ensure smooth integration and minimal impact on existing testing methods.
Trending on Pharmaceutical Technology
1
CPHI Milan Names 2026 Pharma Awards Finalists
2
Lilly's $2.875B Merida Deal Has Implications for Autoantibody Diseases
3
From Phase 1 Screening to Commercial Strategy: Selecting the Right Amorphous Solid Dispersion Technology Early
4
AAPS PharmSci 360: Microstructure Intelligence in Predictive Drug Development, Part 1
5
